JPH0143747B2 - - Google Patents

Info

Publication number
JPH0143747B2
JPH0143747B2 JP55154071A JP15407180A JPH0143747B2 JP H0143747 B2 JPH0143747 B2 JP H0143747B2 JP 55154071 A JP55154071 A JP 55154071A JP 15407180 A JP15407180 A JP 15407180A JP H0143747 B2 JPH0143747 B2 JP H0143747B2
Authority
JP
Japan
Prior art keywords
group
piperazinyl
dihydrocarbostyryl
lower alkyl
alkyl group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP55154071A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5777676A (en
Inventor
Michiaki Tominaga
Nagao Yo
Hidenori Ogawa
Kazuyuki Nakagawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Priority to JP55154071A priority Critical patent/JPS5777676A/ja
Priority to SU813349303A priority patent/SU1426452A3/ru
Priority to DE3153260A priority patent/DE3153260C2/de
Priority to ES507198A priority patent/ES8306743A1/es
Priority to AT0460281A priority patent/AT381701B/de
Priority to ZA817515A priority patent/ZA817515B/xx
Priority to IT8149588A priority patent/IT1210585B/it
Priority to DE3142982A priority patent/DE3142982C2/de
Priority to CA000389068A priority patent/CA1209575A/en
Priority to US06/316,572 priority patent/US4415572A/en
Priority to DK480381A priority patent/DK155665C/da
Priority to GB8132743A priority patent/GB2086896B/en
Priority to MX7855A priority patent/MX155101A/es
Priority to AU76996/81A priority patent/AU524419B2/en
Priority to PH26427A priority patent/PH17962A/en
Priority to CH199/85A priority patent/CH656616A5/de
Priority to PT73910A priority patent/PT73910B/pt
Priority to SE8106430A priority patent/SE448877B/sv
Priority to BE0/206407A priority patent/BE890942A/fr
Priority to CH6942/81A priority patent/CH650782A5/de
Priority to FI813408A priority patent/FI77450C/fi
Priority to NO813678A priority patent/NO158099C/no
Priority to FR8120470A priority patent/FR2493320B1/fr
Priority to NL8104923A priority patent/NL194205C/nl
Priority to KR1019810004240A priority patent/KR860001944B1/ko
Publication of JPS5777676A publication Critical patent/JPS5777676A/ja
Priority to ES520638A priority patent/ES520638A0/es
Priority to ES520637A priority patent/ES8403885A1/es
Priority to AR83292954A priority patent/AR242563A1/es
Priority to AR84296053A priority patent/AR242375A1/es
Priority to NL8403096A priority patent/NL8403096A/nl
Priority to FR848416085A priority patent/FR2552760B1/fr
Priority to DK561984A priority patent/DK159436C/da
Priority to SE8406209A priority patent/SE466655B/sv
Priority to IT8547867A priority patent/IT1226479B/it
Priority to MX848185A priority patent/MX8481A/es
Priority to KR1019860007986A priority patent/KR860001959B1/ko
Priority to KR1019860007985A priority patent/KR860001958B1/ko
Priority to KR1019860007987A priority patent/KR860001960B1/ko
Priority to KR1019860007984A priority patent/KR860001945B1/ko
Publication of JPH0143747B2 publication Critical patent/JPH0143747B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/40—Nitrogen atoms attached in position 8
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
JP55154071A 1980-10-31 1980-10-31 Carbostyril derivative Granted JPS5777676A (en)

Priority Applications (39)

Application Number Priority Date Filing Date Title
JP55154071A JPS5777676A (en) 1980-10-31 1980-10-31 Carbostyril derivative
SU813349303A SU1426452A3 (ru) 1980-10-31 1981-10-29 Способ получени производных карбостирила или их галогенводородных солей
DE3153260A DE3153260C2 (en]) 1980-10-31 1981-10-29
ES507198A ES8306743A1 (es) 1980-10-31 1981-10-29 Procedimiento de preparar compuesto carbostiribicos.
AT0460281A AT381701B (de) 1980-10-31 1981-10-29 Verfahren zur herstellung von neuen carbostyrilverbindungen und ihren pharmazeutisch annehmbaren salzen
ZA817515A ZA817515B (en) 1980-10-31 1981-10-29 Carbostyril compounds,compositions containing same and processes for preparing same
IT8149588A IT1210585B (it) 1980-10-31 1981-10-29 Composti carbostirilici composizioni che li contengono e procedimenti per la loro preparazione
DE3142982A DE3142982C2 (de) 1980-10-31 1981-10-29 Carbostyrilverbindungen, Verfahren zu deren Herstellung und Arzneimittel, welche diese enthalten
CA000389068A CA1209575A (en) 1980-10-31 1981-10-29 Carbostyril compounds, compositions containing same and processes for preparing same
CH6942/81A CH650782A5 (de) 1980-10-31 1981-10-30 Carbostyrilverbindungen, verfahren zu deren herstellung und arzneimittel, welche diese enthalten.
BE0/206407A BE890942A (fr) 1980-10-31 1981-10-30 Nouveaux derives de carbostyrile utiles notamment comme cardiotoniques, leurs procedes de preparation et medicaments les contenant
GB8132743A GB2086896B (en) 1980-10-31 1981-10-30 Carbostyril compounds compositions containing same and process for preparing same
MX7855A MX155101A (es) 1980-10-31 1981-10-30 Procedimiento para la preparacion de derivados de carboestirilo
AU76996/81A AU524419B2 (en) 1980-10-31 1981-10-30 Piperazine-substituted carbostyril compounds
PH26427A PH17962A (en) 1980-10-31 1981-10-30 Carbostyril compounds,compositions containing same
CH199/85A CH656616A5 (de) 1980-10-31 1981-10-30 Carbonsaeureverbindungen und verfahren zu deren herstellung.
PT73910A PT73910B (en) 1980-10-31 1981-10-30 Process for preparing carbostyril compounds and compositions containing same
SE8106430A SE448877B (sv) 1980-10-31 1981-10-30 Karbostyrilforeningar, farmaceutiska kompositioner innehallande dessa och forfaranden for framstellning derav
DK480381A DK155665C (da) 1980-10-31 1981-10-30 Analogifremgangsmaade til fremstilling af carbostyrilforbindelser
US06/316,572 US4415572A (en) 1980-10-31 1981-10-30 Piperazinylcarbostyril compounds
FI813408A FI77450C (fi) 1980-10-31 1981-10-30 Foerfarande foer framstaellning av piperazinylsubstituerade karbostyrilderivat, vilka aer anvaendbara som kardiotoniska medel.
NO813678A NO158099C (no) 1980-10-31 1981-10-30 Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater.
FR8120470A FR2493320B1 (fr) 1980-10-31 1981-10-30 Nouveaux derives de carbostyrile utiles notamment comme cardiotoniques, leurs procedes de preparation et medicaments les contenant
NL8104923A NL194205C (nl) 1980-10-31 1981-10-30 Carbostyrilverbindingen met cardiotonische werking en preparaten die deze verbindingen bevatten.
KR1019810004240A KR860001944B1 (ko) 1980-10-31 1981-10-31 카보스티릴 화합물의 제조방법
ES520637A ES8403885A1 (es) 1980-10-31 1983-03-15 Metodo de preparar compuestos carbostirilicos.
ES520638A ES520638A0 (es) 1980-10-31 1983-03-15 Procedimiento de preparar compuestos carbostirilicos.
AR83292954A AR242563A1 (es) 1980-10-31 1983-05-06 Procedimiento para preparar derivados de (piperazin-1-il)-carboestirilo o de 3,4-dihidrocarboestirilo.
AR84296053A AR242375A1 (es) 1980-10-31 1984-03-21 Procedimiento para preparar compuestos de 5-, 6-,7- u 8-piperazin-carboestirilo o 3,4-dihidrocarboestirilo.
NL8403096A NL8403096A (nl) 1980-10-31 1984-10-11 Piperazinokaneelzuur- en piperazinofenylpropionzuurderivaten en werkwijze voor de bereiding daarvan.
FR848416085A FR2552760B1 (fr) 1980-10-31 1984-10-19 Procede pour l'obtention de derives de carbostyrile et intermediaires de synthese
DK561984A DK159436C (da) 1980-10-31 1984-11-27 Substituerede piperazino-substituerede phenylcarboxylsyreforbindelser
SE8406209A SE466655B (sv) 1980-10-31 1984-12-06 Karboxylsyrafoereningar samt foerfarande foer framstaellning daerav
IT8547867A IT1226479B (it) 1980-10-31 1985-03-26 Composti di acido carbossilico utili come prodotti intermedi per la preparazione di composti carbostirilici
MX848185A MX8481A (es) 1980-10-31 1985-08-09 Procedimiento para preparar compuestos de carboestirilo.
KR1019860007986A KR860001959B1 (ko) 1980-10-31 1986-09-24 카보스티릴 화합물의 제조방법
KR1019860007985A KR860001958B1 (ko) 1980-10-31 1986-09-24 카보스티릴 화합물의 제조방법
KR1019860007987A KR860001960B1 (ko) 1980-10-31 1986-09-24 카보스티릴 화합물의 제조방법
KR1019860007984A KR860001945B1 (ko) 1980-10-31 1986-09-24 카보스티릴 화합물의 제조방법

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP55154071A JPS5777676A (en) 1980-10-31 1980-10-31 Carbostyril derivative

Publications (2)

Publication Number Publication Date
JPS5777676A JPS5777676A (en) 1982-05-15
JPH0143747B2 true JPH0143747B2 (en]) 1989-09-22

Family

ID=15576252

Family Applications (1)

Application Number Title Priority Date Filing Date
JP55154071A Granted JPS5777676A (en) 1980-10-31 1980-10-31 Carbostyril derivative

Country Status (24)

Country Link
US (1) US4415572A (en])
JP (1) JPS5777676A (en])
KR (1) KR860001944B1 (en])
AR (2) AR242563A1 (en])
AT (1) AT381701B (en])
AU (1) AU524419B2 (en])
BE (1) BE890942A (en])
CA (1) CA1209575A (en])
CH (2) CH656616A5 (en])
DE (2) DE3153260C2 (en])
DK (1) DK155665C (en])
ES (3) ES8306743A1 (en])
FI (1) FI77450C (en])
FR (2) FR2493320B1 (en])
GB (1) GB2086896B (en])
IT (2) IT1210585B (en])
MX (1) MX8481A (en])
NL (2) NL194205C (en])
NO (1) NO158099C (en])
PH (1) PH17962A (en])
PT (1) PT73910B (en])
SE (2) SE448877B (en])
SU (1) SU1426452A3 (en])
ZA (1) ZA817515B (en])

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993000902A1 (en) 1991-07-03 1993-01-21 Otsuka Pharmaceutical Co., Ltd. Apoptosis regulator

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5883677A (ja) * 1981-11-11 1983-05-19 Otsuka Pharmaceut Co Ltd カルボスチリル誘導体
JPS5929667A (ja) * 1982-08-13 1984-02-16 Otsuka Pharmaceut Co Ltd カルボスチリル誘導体および強心剤
CH655110A5 (de) * 1982-09-03 1986-03-27 Otsuka Pharma Co Ltd Carbostyrilderivate, verfahren zu deren herstellung und arzneimittel, welche diese enthalten.
US4730000A (en) * 1984-04-09 1988-03-08 Abbott Laboratories Quinoline antibacterial compounds
DK169601B1 (da) * 1983-10-17 1994-12-19 Duphar Int Res Piperazinderivater og farmaceutisk præparat indeholdende et sådant derivat, samt piperazinderivater med mellemproduktanvendelse
JPS60126270A (ja) * 1983-12-14 1985-07-05 Otsuka Pharmaceut Co Ltd カルボスチリル誘導体
PT79699B (en) * 1983-12-22 1986-12-10 Pfizer Process for preparing quinolone inotropic agents
US4774246A (en) * 1984-01-26 1988-09-27 Abbott Laboratories Quinoline antibacterial compounds
NZ212209A (en) * 1984-05-29 1988-08-30 Pfizer Quinolone derivatives and pharmaceutical compositions
JPS60256133A (ja) * 1984-06-01 1985-12-17 Fuji Photo Film Co Ltd 放射線画像情報記録読取装置
EP0168003B1 (en) * 1984-07-06 1991-04-03 Otsuka Pharmaceutical Co., Ltd. Oxindol compounds, compositions containing same and processes for preparing same
US4760064A (en) * 1984-12-18 1988-07-26 Otsuka Pharmaceutical Co., Ltd. Carbostyril compounds, compositions containing same and processes for preparing same
JPH07100696B2 (ja) * 1984-12-18 1995-11-01 大塚製薬株式会社 カルボスチリル誘導体
JPS61145162A (ja) * 1984-12-19 1986-07-02 Otsuka Pharmaceut Co Ltd カルボスチリル誘導体
ATE81975T1 (de) * 1984-12-21 1992-11-15 Duphar Int Res Arzneimittel mit psychotroper wirkung.
ATE44528T1 (de) * 1984-12-21 1989-07-15 Duphar Int Res Arzneimittel mit antipsychotischer wirkung.
US4845100A (en) * 1985-04-12 1989-07-04 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives and salts thereof, processes for preparing the same and cardiotonic composition containing the same
DE3524067A1 (de) * 1985-07-05 1987-01-08 Boehringer Mannheim Gmbh Neue benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte
US4666913A (en) * 1985-11-22 1987-05-19 William H. Rorer, Inc. Hydroxy and aminothiazolyl-benzodiazinone compounds, cardiotonic compositions including the same, and their uses
GB8529362D0 (en) * 1985-11-28 1986-01-02 Pfizer Ltd Quinolone cardiac stimulants
JPH0625123B2 (ja) * 1985-12-12 1994-04-06 大塚製薬株式会社 カルボスチリル誘導体−シクロデキストリン包接化合物
US4689325A (en) * 1985-12-23 1987-08-25 Abbott Laboratories Isoxazolo-pyrido-phenoxazine and isothiazolo-pyrido-phenoxazine derivatives
US4687770A (en) * 1985-12-23 1987-08-18 Abbott Laboratories Isoxazolo-pyrido-benzoxazine and isothiazolo-pyrido-benzoxazine derivatives
US5358949A (en) * 1986-03-05 1994-10-25 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives and salts thereof and anti-arrhythmic agents containing the carbostyril derivatives
DK111387A (da) * 1986-03-05 1987-09-06 Otsuka Pharma Co Ltd Carbostyrilderivater og salte deraf, laegemiddel indeholdende saadanne derivater samt fremgangsmaade til fremstilling af derivaterne
GB8630702D0 (en) * 1986-12-23 1987-02-04 Wellcome Found Quinoline compound
US5166160A (en) * 1986-12-23 1992-11-24 Burroughs Wellcome Co. Quinoline compound
JPS63225357A (ja) * 1987-03-12 1988-09-20 Otsuka Pharmaceut Co Ltd カルボスチリル誘導体
GB8827189D0 (en) * 1988-11-21 1988-12-29 Fujisawa Pharmaceutical Co 2(1h)-quinolinone compounds processes for preparation thereof & pharmaceutical composition comprising same
US5750529A (en) * 1991-07-03 1998-05-12 Otsuka Pharmaceutical Co., Ltd. Apoptosis regulating compostion
WO1993011769A1 (en) * 1991-12-10 1993-06-24 Otsuka Pharmaceutical Co., Ltd Carcinostatic
JP2686887B2 (ja) * 1992-08-11 1997-12-08 キッセイ薬品工業株式会社 ピペリジノ−３，４−ジヒドロカルボスチリル誘導体
CA2121148A1 (en) * 1992-08-19 1994-03-03 Satoru Nakai Apoptosis regulator
JP2826790B2 (ja) * 1992-12-26 1998-11-18 キッセイ薬品工業株式会社 ３，４−ジヒドロカルボスチリル誘導体
KR0185226B1 (ko) * 1993-03-02 1999-05-01 오오쓰까 아끼히꼬 이식 조직의 거부반응 억제제 및 il-1 생산 억제제
JPH0733664A (ja) * 1993-07-26 1995-02-03 Otsuka Pharmaceut Co Ltd 平滑筋細胞増殖抑制剤
GB9326232D0 (en) * 1993-12-23 1994-02-23 Zeneca Ltd Chemical compounds
GB9326373D0 (en) * 1993-12-23 1994-02-23 Zeneca Ltd Chemical compounds
US5504093A (en) * 1994-08-01 1996-04-02 Otsuka Pharmaceutical Co., Ltd. Method for inhibiting nucleoside and nucleobase transport in mammalian cells, and method for inhibition of DNA virus replication
PT889889E (pt) * 1996-03-29 2007-01-31 Duphar Int Res Composto de piperazina e piperidina
GB2312843A (en) * 1996-05-07 1997-11-12 Merck & Co Inc Method of treating rheumatoid arthritis
US5684007A (en) * 1996-09-05 1997-11-04 Otsuka Pharmaceutical Co., Ltd. Methods for inhibiting cardiac fibroblast growth and cardiac fibrosis
CA2378298A1 (en) 1999-08-27 2001-03-08 Lawrence G. Hamann 8-substituted-6-trifluoromethyl-9-pyrido¬3,2-g|quinoline compounds as androgen receptor modulators
US6566372B1 (en) * 1999-08-27 2003-05-20 Ligand Pharmaceuticals Incorporated Bicyclic androgen and progesterone receptor modulator compounds and methods
IL148045A0 (en) * 1999-08-27 2002-09-12 Ligand Pharm Inc Androgen receptor modulator compounds and methods
EP1216221A2 (en) 1999-09-14 2002-06-26 Ligand Pharmaceuticals Incorporated Rxr modulators with improved pharmacologic profile
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US7816372B2 (en) * 2003-08-22 2010-10-19 Ligand Pharmaceuticals Incorporated 6-cycloamino-2-quinolinone derivatives as androgen receptor modulator compounds
WO2006097459A1 (en) * 2005-03-14 2006-09-21 Nycomed Gmbh Method for preventing cardiovascular diseases
KR101289995B1 (ko) 2005-09-27 2013-07-26 시오노기 앤드 컴파니, 리미티드 Ｐｇｄ2 수용체 길항제 활성을 갖는 설폰아마이드 유도체
US8034782B2 (en) 2008-07-16 2011-10-11 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
ES2393885T7 (es) 2007-06-04 2014-01-30 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
WO2009149279A2 (en) 2008-06-04 2009-12-10 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CN108676076A (zh) 2011-03-01 2018-10-19 辛纳吉制药公司 制备鸟苷酸环化酶c激动剂的方法
EP3718557A3 (en) 2013-02-25 2020-10-21 Bausch Health Ireland Limited Guanylate cyclase receptor agonist sp-333 for use in colonic cleansing
JP2016514670A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド 他の薬物と組み合わせたグアニル酸シクラーゼ受容体アゴニスト
CA2905438A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
RS65632B1 (sr) 2013-06-05 2024-07-31 Bausch Health Ireland Ltd Ultra-prečišćeni agonisti guanilat-ciklaze c, postupak njihove pripreme i upotrebe
US20160184387A1 (en) 2013-08-09 2016-06-30 Dominique Charmot Compounds and methods for inhibiting phosphate transport
JP2022533251A (ja) 2019-05-21 2022-07-21 アルデリックス， インコーポレイテッド 患者において血清リン酸塩を低下させるための組み合わせ

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1278385B (de) * 1965-03-30 1968-09-26 Bayer Ag Aufhellungsmittel
GB1299172A (en) * 1968-10-15 1972-12-06 Lilly Industries Ltd Heterocyclic anti-inflammatory agents
DE2719562C2 (de) * 1976-05-08 1986-05-07 Otsuka Pharmaceutical Co. Ltd., Tokio/Tokyo 3, 4-Dihydrocarbostyrilderivate, Verfahren zu deren Herstellung und Arzneimittel, welche diese enthalten
JPS54130589A (en) * 1978-03-31 1979-10-09 Yoshitomi Pharmaceut Ind Ltd Pyridazine derivative and its preparation
JPS54135785A (en) * 1978-04-12 1979-10-22 Yoshitomi Pharmaceut Ind Ltd Pyridazinone derivative and its preparation
JPS54138585A (en) * 1978-04-18 1979-10-27 Yoshitomi Pharmaceut Ind Ltd Pyridazine derivative and its preparation
JPS54141785A (en) * 1978-04-26 1979-11-05 Yoshitomi Pharmaceut Ind Ltd Preparation of carboxylic acid derivative
JPS6017072B2 (ja) * 1978-09-05 1985-04-30 三菱電機株式会社 赤熱金属検出器
JPS5549319A (en) * 1978-10-06 1980-04-09 Yoshitomi Pharmaceut Ind Ltd Remedy for suppression of blood platelet-agglutination
JPS5553283A (en) * 1978-10-12 1980-04-18 Yoshitomi Pharmaceut Ind Ltd Pyridazinone derivative
JPS5576872A (en) * 1978-12-06 1980-06-10 Yoshitomi Pharmaceut Ind Ltd Imidazolidinone derivative
JPS5583781A (en) * 1978-12-19 1980-06-24 Yoshitomi Pharmaceut Ind Ltd Pyridazinone derivative

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993000902A1 (en) 1991-07-03 1993-01-21 Otsuka Pharmaceutical Co., Ltd. Apoptosis regulator

Also Published As

Publication number Publication date
AU7699681A (en) 1982-05-06
AR242375A1 (es) 1993-03-31
IT1210585B (it) 1989-09-14
DK480381A (da) 1982-05-01
JPS5777676A (en) 1982-05-15
SE8106430L (sv) 1982-05-01
SU1426452A3 (ru) 1988-09-23
ES507198A0 (es) 1983-06-16
GB2086896A (en) 1982-05-19
SE448877B (sv) 1987-03-23
NO158099B (no) 1988-04-05
ES520637A0 (es) 1984-04-16
PT73910B (en) 1983-04-18
NL194205C (nl) 2001-09-04
ES8306743A1 (es) 1983-06-16
ZA817515B (en) 1982-10-27
AR242563A1 (es) 1993-04-30
IT1226479B (it) 1991-01-16
NL8403096A (nl) 1985-02-01
IT8547867A0 (it) 1985-03-26
FI813408L (fi) 1982-05-01
DE3142982C2 (de) 1985-12-19
FI77450B (fi) 1988-11-30
NO158099C (no) 1988-07-13
NO813678L (no) 1982-05-03
IT8149588A0 (it) 1981-10-29
AT381701B (de) 1986-11-25
SE8406209L (sv) 1984-12-06
FR2552760A1 (fr) 1985-04-05
FI77450C (fi) 1989-03-10
KR860001944B1 (ko) 1986-11-01
GB2086896B (en) 1984-10-10
CA1209575A (en) 1986-08-12
DK155665C (da) 1989-09-04
DK155665B (da) 1989-05-01
ES8403886A1 (es) 1984-04-16
SE8406209D0 (sv) 1984-12-06
DE3153260C2 (en]) 1989-05-24
ATA460281A (de) 1986-04-15
CH650782A5 (de) 1985-08-15
ES520638A0 (es) 1984-04-16
CH656616A5 (de) 1986-07-15
ES8403885A1 (es) 1984-04-16
PT73910A (en) 1981-11-01
FR2493320A1 (fr) 1982-05-07
MX8481A (es) 1994-02-28
DE3142982A1 (de) 1982-06-24
SE466655B (sv) 1992-03-16
FR2552760B1 (fr) 1988-08-05
NL194205B (nl) 2001-05-01
AU524419B2 (en) 1982-09-16
BE890942A (fr) 1982-02-15
FR2493320B1 (fr) 1985-08-23
DE3153260A1 (en]) 1985-05-15
NL8104923A (nl) 1982-05-17
KR830007607A (ko) 1983-11-04
PH17962A (en) 1985-02-20
US4415572A (en) 1983-11-15

Similar Documents

Publication Publication Date Title
JPH0143747B2 (en])
US5206366A (en) Process for preparing aryl piperazinyl-heterocyclic compounds
EP1268466B1 (en) Decahydro-isoquinolines
JPS6084282A (ja) １−ヘテロアリ−ル−４−〔（２．５−ピロリジンジオン−１−イル）アルキル〕ピペラジン誘導体
SE445348B (sv) Karbostyrilderivat, forfarande for framstellning derav och hjertsterkande komposition som innehaller detsamma
JPH06293753A (ja) ２−〔４−〔（４，４−ジアルキル−２、６−ピペリジン ジオン−１−イル）ブチル〕−１−ピペラジニル〕ピリミジン含有組成物
JPH08109169A (ja) 非ペプチドタキキニン受容体拮抗物質
HUP0203225A2 (hu) Benzodiazepinszármazékok, előállításuk és alkalmazásuk
SK1582003A3 (en) Benzimidazole derivatives, preparation and therapeutic use thereof
JP2008543782A (ja) ５−ｈｔ１ａ受容体のピペラジン−ピペリジンアンタゴニストおよびアゴニスト
US5457099A (en) Carbostyril derivatives and antiallergic agent
JPH0314308B2 (en])
JPS61148175A (ja) ヒドロキシもしくはアミノ置換（ピペリジニルアルキル）キナゾリン類
JPH0314023B2 (en])
RU2378275C2 (ru) ПРОИЗВОДНЫЕ ПИРРОЛО[3,2-c]ПИРИДИНА И СПОСОБ ИХ ПОЛУЧЕНИЯ
JPH0141128B2 (en])
US7994189B2 (en) Dihydropyridine derivatives
RU2038355C1 (ru) Способ получения 3-(1-тиазолидинилбутил-4-пиперазинил)-1н-индазолов
JPS6338005B2 (en])
JP2003518098A (ja) ウイルス感染の治療に用いるキノロン化合物
JPH0215537B2 (en])
US4260612A (en) Antiallergic nitrogen bridge-head compounds
JPH0696555B2 (ja) カルボスチリル誘導体
JPS6130588A (ja) ベンゾ〔ｃ〕〔１，８〕ナフチリジン、その製造方法及びその使用、並びにこれらの化合物を含有する調製剤
JPH0216299B2 (en])